Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05511246 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Venous Ethanol for Ventricular Tachycardia

Study acronym: VELVET
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria expanded, about 46 wordsv5 See this version in full on ClinicalTrials.gov ↗
  2. Re-verified, no change to tracked fieldsv4
  3. Site contact updatedv3
  4. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Primary completion date: Dec 2027 to Dec 12, 2027 · Completion date: Dec 2028 to Dec 12, 2028 · 1 morev2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Dec 2027 to Dec 12, 2027
    • Completion date: Dec 2028 to Dec 12, 2028
    • Start date changed from estimate of Jan 2023 to Apr 12, 2023
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Comparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequency ablation combined with venous ethanol in patients with ischemic ventricular tachycardia -Venous Ethanol for Left Ventricular Ischemic Ventricular Tachycardia -VELVET clinical trial
Trial Details
NCT Number NCT05511246
Lead Sponsor The Methodist Hospital Research Institute
Conditions Ventricular Tachycardia, Ischemic Cardiomyopathy
Enrollment 156 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov